Money20/20 Unveils Global Powerhouse Jury for Inaugural Money Awards
21.5.2025 13:48:00 CEST | Business Wire | Press release
Distinguished Global Leaders to Judge Transformative Innovation in Fintech
Money20/20, the world's leading fintech show, and the place where money does business, today announced its inaugural jury for The Money Awards, featuring an unprecedented assembly of distinguished leaders from across the global financial technology ecosystem from traditional banks, fintechs, neobanks, venture capitalists, and the world’s most influential brands. The jury represents in-depth knowledge and expertise from around the world spanning North America, Europe, Latin America, Asia, Middle-East and Africa, reinforcing the awards' position as the definitive global benchmark for fintech excellence.
The jury lineup for the Money Awards are:
Banking Award
Jury President:
Joanne Hannaford, Chief Information Officer & Chief Product Officer Corporate Bank, Deutsche Bank
Jury Members:
Annerie Vreugdenhil, Chief Commercial Officer Personal & Business Banking, ABN AMRO N.V.
Elizabeth Jimenez, Senior Vice President, Strategic Risk, Citi
Glauber Mota, CEO, Revolut
John Piazza, Head of Product, Newline by Fifth Third
Lukasz Strozek, Chief Technology Officer, LendingClub
Nobutake Suzuki, President & CEO, MUFG Innovation Partners Co., Ltd.
Tosin Eniolorunda, Founder & Group CEO, Moniepoint Inc.
Diamond Award
Jury President:
Lynn Martin, President, NYSE Group
Jury Members:
Manolo Sánchez, CEO, Adelante Ventures LLC
Nico Kersten, CEO & Managing Director, Mercedes pay GmbH
Suzan Kereere, President, Global Markets, PayPal
Tim Shen, CEO, LianLian Global
Payments Award
Jury President:
Howard R. Fields, Chief Ethics & Compliance Officer, Mastercard
Jury Members:
Brigette Korney, Global Head of Risk, Adyen
Camilla Bullock, CEO, Emerging Payments Association Asia
Meron Colbeci, Chief Product Officer, Checkout.com
Neetika Bansal, Head of Money Management & Crypto, Stripe
Olugbenga Agboola, Founder & CEO, Flutterwave Inc.
Pebbles Sy, Chief Technology & Operations Officer, GCash
Prajit Nanu, CEO, Nium
Theresa Gongora, Executive Vice President, Merchant Solutions, Global Payments, Inc.
Partnerships & Strategic Alliance Award
Jury President:
Anthony Thomas, Managing Director, FinTech, Delivery Hero
Jury Members:
Jose Antonio Murillo, CEO, RappiCard
Joyce Lim, Director of Global Payments, Expedia Group
Mariette Ferreira, Chief Marketing Officer, PPRO
Mohammed Alzubi, Founder & Managing Partner, Nama Ventures
Ranjit Sarai, VP Digital & Ecosystem, Canada, Western Union
Sarah Kocianski, CEO, FinTech Wales
Suvo Sarkar, Host, Money Majlis podcast, Founder & CEO, 3D Advisory
Startup Award
Jury President:
Chetan Puttagunta, General Partner, Benchmark
Jury Members:
Annie Guo, CEO, Silkpay
Mareme Dieng, Partner, 500 Global
Mariel Vasquez, Head of Innovation & Growth, HSBC Mexico
Mark Fiorentino, Partner, Bain Capital Ventures
Noam Inbar, Partner, Viola Fintech
Steph Choo, General Partner, Portage
Vicky Bindra, CEO, Trulioo
Vishnu Acharya, Head of Strategy, M&A, Investments, Razorpay
"The Money Awards Jury plays a vital role in setting the global benchmark for recognizing transformative innovation across the fintech ecosystem.The caliber and diversity of our jury panel reflects the truly global nature of financial innovation," said Grania Chesterton, Vice President of Awards at Money20/20. "By bringing together voices from established financial capitals and emerging fintech hubs, we're ensuring that The Money Awards recognize excellence that transcends geographical boundaries and represents the future of finance on a truly global scale."
Jurors will evaluate submissions through a transparent and impartial process that includes online reviews followed by in-person deliberations at Money20/20 USA. The winners will be announced live at Money20/20 USA in Las Vegas in October, ensuring global recognition.
Winners will receive a bespoke trophy and benefit from year-round visibility through Money20/20’s platforms, including exclusive speaking opportunities, media exposure, investor visibility, and networking at Money20/20 shows worldwide. Entries are open now and are live until the 29th of July.
For more information about The Money Awards, visit www.money2020.com/award.
About Money20/20
Launched by industry insiders in 2012, Money20/20 has rapidly become the heartbeat of the global fintech ecosystem. Over the last decade, the most innovative, fast-moving ideas and companies have driven their growth on our platform. Mastercard, Wise, J.P. Morgan, SHIELD, Convera, Stripe, Google, VISA, Adyen, and more make transformational deals and raise their global profile with us. Money20/20 attracts leaders from the world’s greatest banks, payments companies, VC firms, regulators and media platforms: convening to cut industry-shaping deals, build world-changing partnerships and unlock future-defining opportunities in Bangkok (22-24 April 2025) in Amsterdam (3-5 June 2025), in Riyadh ( 15-17 September 2025), and in Las Vegas (26-29 October 2025). Money20/20 is where the world’s fintech leaders convene to grow their businesses. Money20/20 is part of Informa Festivals. Follow Money20/20 on X and LinkedIn for show developments and updates. We’re Where Money Does Business. Follow Money20/20 on X for show developments and updates. You can also find us on LinkedIn at Money20/20.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250521771868/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom